TY  - GEN
AU  - Kreutzer,Thomas C
AU  - Wolf,Armin
AU  - Dirisamer,Martin
AU  - Strauss,Rupert W
AU  - Foerster,Paul
AU  - Feltgen,Nicolas
AU  - Pielen,Amelie
AU  - Hattenbach,Lars-Olof
AU  - Kampik,Anselm
AU  - Priglinger,Siegfried G
TI  - Intravitreal ranibizumab versus isovolemic hemodilution in the treatment of macular edema secondary to central retinal vein occlusion: twelve-month results of a prospective, randomized, multicenter trial
SN  - 1423-0267
PY  - 2015///1009
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Angiogenesis Inhibitors
KW  - therapeutic use
KW  - Antibodies, Monoclonal, Humanized
KW  - Blood Viscosity
KW  - Female
KW  - Fluorescein Angiography
KW  - Hemodilution
KW  - methods
KW  - Humans
KW  - Intravitreal Injections
KW  - Macular Edema
KW  - drug therapy
KW  - Male
KW  - Middle Aged
KW  - Prospective Studies
KW  - Ranibizumab
KW  - Retinal Vein Occlusion
KW  - complications
KW  - Tomography, Optical Coherence
KW  - Vascular Endothelial Growth Factor A
KW  - antagonists & inhibitors
KW  - Visual Acuity
KW  - physiology
N1  - Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1159/000369566
ER  -